What Is BXO in Urology? Symptoms, Diagnosis & Treatment

Balanitis xerotica obliterans, usually called BXO, is a chronic inflammatory skin condition that affects the penis, specifically the foreskin, the head (glans), and sometimes the urethral opening or deeper urethral tissue.¹ It is the male genital form of a broader condition called lichen sclerosus. In urology clinics, it shows up as whitish, scarred skin that progressively tightens, and it can cause problems ranging from a foreskin that will not retract to urinary obstruction. The condition is more common than older textbooks suggested, and recognizing it early makes a meaningful difference in outcomes.

What BXO Actually Is

BXO is classified as a rare, acquired, non-infectious, and chronically inflammatory skin disease with an autoimmune component.² “Rare” here is somewhat misleading, because many mild cases go undiagnosed or are only discovered incidentally during circumcision. The cause remains unknown. Researchers have investigated autoimmune triggers, genetic susceptibility, chronic irritation from urine exposure, and even infectious agents, but no single explanation has held up consistently. What is clear is that the disease involves a cycle of inflammation, scarring, and tissue hardening that, left alone, tends to get worse over time rather than better.

Dermatologists call the same condition lichen sclerosus (LS), which can affect any area of skin but has a strong preference for the genital region in both men and women. When it appears on the male genitals, urologists historically called it BXO. The two names refer to the same disease process, and you will see both in medical literature. Understanding that BXO equals penile lichen sclerosus is useful when researching the condition, because some treatment studies use one name and some use the other.

Recognizing the Symptoms

The earliest symptom most men notice is a foreskin that becomes progressively harder to pull back. In a boy or man who previously had no trouble retracting the foreskin, this new tightness, called secondary phimosis, is a red flag. The skin of the foreskin or glans develops pale, whitish patches that look waxy or porcelain-like. These patches may crack or bleed during erection or intercourse.

A useful clinical mnemonic summarizes the typical presentation as the “6 S’s”: school age onset, secondary phimosis, severe sclerotic (hardened) lesions on the glans, and meatal stenosis (narrowing of the urinary opening).³ Common complaints include discomfort after urinating, a deflected or spraying urinary stream, and difficulty with erections that becomes painful as the scarring worsens. Some men also notice itching or burning of the affected skin, though pain is not always present in early stages.

Voiding problems are less common initially but carry serious consequences. When scarring extends to the urethral opening or into the urethra itself, the narrowing can obstruct urine flow. In severe, neglected cases, this has been reported to progress as far as kidney damage from chronic back-pressure.³ That extreme outcome is unusual, but it underscores why a urinary stream that gradually weakens or deflects deserves medical attention.

How BXO Is Diagnosed

In most cases, an experienced urologist or dermatologist can diagnose BXO by looking at the affected tissue. The combination of whitish, scarred skin on the foreskin or glans with secondary phimosis is considered clinically distinctive. A biopsy is not required in every case; it is mainly indicated when the appearance is atypical, when there is concern about penile cancer, or when the diagnosis is uncertain.⁴ Under the microscope, BXO has a recognizable pattern: thickened outer skin layer, a washed-out appearance of the tissue just beneath the surface, and a band of dense collagen with chronic inflammatory cells deeper down.⁵

Several other conditions can look similar at a glance. Lichen planus, vitiligo, localized scleroderma, and leukoplakia all produce white or pale patches on genital skin.⁵ A particularly important condition to rule out is erythroplasia of Queyrat, which is a form of penile pre-cancer that can occasionally coexist with BXO. When a biopsy is taken, the pathologist can reliably distinguish these conditions based on the tissue architecture.

BXO in Children

One of the more confusing aspects of BXO is how it overlaps with normal childhood phimosis. Most boys are born with a foreskin that does not fully retract, and this resolves naturally with age. Pathological phimosis from BXO, by contrast, involves scarring that will not resolve on its own and typically presents later in childhood. In one study of 40 boys referred for suspected phimosis, only five turned out to have true pathological phimosis, and three of those five had BXO with the classic thick, scarred foreskin and grey-white discoloration.⁶ One of those children also had meatal stenosis requiring an additional procedure to widen the urinary opening.

Getting the diagnosis right in children matters because the treatment paths diverge sharply. Normal developmental phimosis often resolves with gentle retraction or topical steroids, while BXO-related phimosis almost always requires circumcision. However, clinical diagnosis in boys is not straightforward. One study found that the appearance of the foreskin alone had a diagnostic accuracy of about 75% compared to what the pathologist found after surgery.⁷ When doctors combined foreskin appearance with a history of other allergic or immune conditions and prior episodes of foreskin inflammation, the specificity and positive predictive value reached 100%, meaning a child who met all those criteria almost certainly had BXO. But sensitivity dropped dramatically, so many children with actual BXO did not meet the full set of clinical criteria beforehand.

Age matters too. A study of boys referred for circumcision found that BXO confirmed by tissue pathology was present in roughly 9% of children over age five, compared to under 2% of those younger than five.⁸ This fits with the general observation that BXO-related phimosis tends to appear in school-age boys rather than toddlers, though exceptions exist.

Medical Treatment

The first-line medical treatment is a potent topical corticosteroid. Clobetasol propionate 0.05% ointment or mometasone furoate 0.1% ointment, applied to the affected skin for about three months, clears or significantly improves the condition in roughly 35 to 60 percent of male patients.⁹ That success rate is encouraging for early or mild disease, but it also means a substantial number of patients do not respond adequately to steroids alone.

Prolonged use of potent steroids on genital skin introduces its own problems: thinning of the skin, visible blood vessels, lightened skin color, and increased vulnerability to infections. These side effects are a practical concern because BXO is a chronic condition that may flare after treatment stops. An alternative that avoids those steroid-specific risks is the calcineurin inhibitor class of topical medications, specifically tacrolimus 0.1% or pimecrolimus 1% ointment. A three-month course of either agent is considered a safe and effective second-line option.⁹ These work by dampening the local immune response without the skin-thinning effects of steroids.

Medical treatment works best when the disease is caught early, before dense scarring has set in. Once the tissue has undergone substantial fibrosis, no cream is going to reverse the structural damage. This is one reason urologists emphasize that men with suspicious white patches or a newly tight foreskin should seek evaluation sooner rather than later.

When Surgery Becomes Necessary

Circumcision is the most common surgical treatment for BXO, and when the disease is limited to the foreskin, circumcision alone is often curative.⁵ By removing the affected foreskin, the cycle of chronic inflammation under tightly scarred tissue is broken. In one large pediatric series spanning ten years, about 88% of patients needed only circumcision, while 11% required an additional procedure to address narrowing at the urethral opening.¹⁰

For children and adults whose disease involves meatal stenosis, a meatotomy (a small cut to widen the urethral opening) or meatoplasty (a more involved reconstruction of the opening) is performed alongside the circumcision. This step is critical because the narrowed opening causes the obstructive urinary symptoms that make BXO more than a cosmetic problem.

An important surgical lesson has emerged over the years regarding tissue choice for reconstruction. When BXO-related urethral strictures need repair, using penile skin as the graft material fails at very high rates because the disease can recur in the transplanted skin. One study found that treatment failed in every patient who underwent reconstruction with a penile skin flap, while a staged procedure using a free graft had a far lower failure rate.¹¹ This finding shifted reconstructive practice toward buccal mucosa, the tissue lining the inside of the cheek, which appears resistant to BXO and has become the graft material of choice for urethral rebuilding in these patients.

Urethral Strictures and Reconstruction

When BXO progresses beyond the foreskin and glans into the urethra, the resulting strictures represent the most challenging aspect of the disease. Most BXO-related strictures affect the front portion of the urethra near the opening. In one series, about three-quarters of patients had strictures shorter than two centimeters, while about a quarter had longer strictures.¹² Shorter strictures are generally more amenable to straightforward surgical repair, while longer ones may require staged reconstruction.

Buccal mucosal graft urethroplasty, where a strip of tissue from inside the cheek is used to widen or rebuild the narrowed urethra, has shown strong results. In a study of boys who underwent single-stage repair with buccal mucosal graft, peak urinary flow rates improved from an average of about 4 mL per second before surgery to 26 mL per second afterward, with all patients achieving a successful functional outcome over a median follow-up of nearly three years.¹³ That kind of improvement in flow rate translates directly to relief from the straining and slow stream that patients experience preoperatively.

Recurrence after surgical treatment is a genuine concern with BXO, however. In a study of patients who had undergone excision and staged urethroplasty for meatal disease, four out of ten developed visible recurrence of BXO at the surgical site over a follow-up period that ranged from under two years to nearly nine years.¹⁴ This means that even after apparently successful surgery, patients need ongoing monitoring to catch any return of disease early.

The Link to Penile Cancer

One of the more serious concerns with long-standing BXO is its association with squamous cell carcinoma of the penis. The chronic inflammation and scarring that define BXO appear to create a tissue environment in which malignant changes are more likely over time. Case reports have documented patients in whom penile carcinoma developed in the setting of long-standing BXO, often alongside urethral strictures and meatal stenosis.¹⁵

The overall risk is considered low, but it is not negligible, and it reinforces the importance of lifelong surveillance. Any man with a history of BXO who notices a new lump, non-healing ulcer, or change in the appearance of a previously stable lesion should seek prompt evaluation. Biopsy of suspicious areas remains the gold standard for ruling out malignancy. This cancer risk is one reason why the approach of simply ignoring BXO and “living with it” is discouraged by urologists.

Impact on Sexual and Urinary Function

BXO can significantly affect quality of life in ways that go beyond the visible skin changes. The disease is associated with impaired urinary and sexual function.¹⁶ Painful erections from scarred, inelastic skin on the glans are among the most distressing symptoms men report. Intercourse can become uncomfortable or impossible when the disease is advanced. Loss of sensitivity in the glans due to the sclerotic changes is another complaint, though this is harder to quantify.

The chronic, progressive nature of the condition also takes a psychological toll. Many men with BXO delay seeking care out of embarrassment, and by the time they present to a urologist, the disease has progressed beyond the point where conservative treatment is likely to work. Urologists familiar with the condition emphasize that early presentation and treatment preserve the best chances for maintaining normal sexual and urinary function.¹⁷

Emerging Treatments

Given the limitations of current therapies, particularly the recurrence rates after surgery and the incomplete response to topical steroids, interest in newer approaches is growing. Topical tacrolimus, already mentioned as a steroid alternative, has also been explored specifically for BXO-related urethral strictures, with early reports suggesting improvement in partially obstructed strictures.¹² If confirmed in larger studies, this could offer a non-surgical option for patients with mild to moderate urethral narrowing.

Laser therapy has attracted attention for lichen sclerosus in general, including the genital form. A systematic review of the existing evidence for laser treatment found limited but suggestive results. In one study using fractional CO2 laser combined with autologous plasma, about half of participants became asymptomatic, and several others experienced reduced symptoms.¹⁸ The evidence base for laser therapy in male genital lichen sclerosus specifically remains thin, however, and most of the existing laser literature focuses on vulvar disease in women. Whether these early results translate into a practical treatment option for BXO awaits larger, controlled trials.

Platelet-rich plasma injections, fat grafting, and other regenerative medicine approaches have been reported anecdotally, but none has yet generated the kind of evidence that would place it alongside established treatments. For now, the practical treatment ladder for BXO remains topical steroids for early disease, circumcision when the foreskin is involved, and buccal mucosal graft urethroplasty for urethral strictures, with long-term follow-up regardless of which treatment is used.

Why Follow-Up Matters More Than You Might Think

BXO is not a condition where you get treated once and move on. The disease can recur after both medical and surgical treatment, sometimes years later. Even after circumcision resolves the foreskin component, the glans and urethral opening remain at risk. The recurrence pattern seen in meatal disease, where disease returned in four of ten patients after staged surgery, illustrates this point.¹⁴ A man or boy who has been treated for BXO should have periodic examinations to check for new white patches, meatal narrowing, or changes in urinary stream. These visits do not need to be frequent forever, but abandoning follow-up entirely is a mistake given the chronic nature of the disease and the small but real risk of malignant transformation.

For parents of boys diagnosed with BXO, the reassurance is that circumcision alone resolves the problem in the large majority of cases, and serious complications like urethral stricture are the exception rather than the rule. For adult men, the prognosis depends heavily on how advanced the disease is at diagnosis. Catching BXO while it is still limited to superficial skin changes offers the best chance of controlling it with topical therapy or a straightforward circumcision, while waiting until urethral involvement develops means facing more complex surgery and a higher likelihood of recurrence.